Neuramis: Medytox hyaluronic acid fillers and what is known

You may have been offered Neuramis for a fold or lost volume but do not want to look like somebody else, and you may wonder how it differs from other fillers. Neuramis is a family of injectable hyaluronic acid fillers made by Medytox. Unlike botulinum toxin, filler adds physical volume rather than temporarily reducing muscle contraction. For a suitable concern it may soften certain folds or restore some contours, but it cannot promise a surgical lift, correction of all wrinkles or freedom from complications. First clarify the exact Neuramis product, the treatment area and the clinician's qualifications.

Why isn't “Do you offer Neuramis?” specific enough?

Neuramis is not one all-purpose syringe for every part of the face. The manufacturer lists Light Lidocaine, Lidocaine, Deep, Deep Lidocaine and Volume Lidocaine. Their formulations, properties and intended applications should not be assumed to be identical. Lidocaine is a local anaesthetic added to some products to reduce injection discomfort; discuss it specifically if you have allergies or a history of reactions. Some versions are described for particular tissue planes; a properly trained clinician must choose depth and technique.

Medytox describes a stabilised hyaluronic acid gel, chemically cross-linked to help it retain its form for longer. Hyaluronic acid also occurs naturally in human tissues, but the injectable gel is a medical device with its own physical characteristics, sterile requirements, indications and restrictions. “Natural substance” does not mean “incapable of causing serious harm”. Area, blood vessels, technique and your health also influence risk.

The manufacturer describes specific Neuramis variants, but its product materials do not establish supply to Armenia: the range, packs, instructions and regulatory status can vary between countries. Ask for the exact name on the original pack, the instructions for that particular version, registration documents for the country of treatment, batch number and expiry date. Registration of one version in one jurisdiction does not establish registration of every version elsewhere. An advertisement for Neuramis does not establish actual availability or lawful use at a particular Armenian facility.

When might filler help, and when is it the wrong method?

Filler is most relevant when the concern is missing volume or a fold that can reasonably respond to added gel. Two similar-looking wrinkles can have different causes: facial movement, changes in bony support, loss of fat, ligament laxity, excess loose skin or surface dryness. An injection does not replace an examination of these causes. Sometimes someone wants a fold filled but direct injection would add unwanted heaviness.

Your goal	What an examination should clarify	What cannot be promised
Soften nasolabial folds	How much of the fold reflects volume, and how much comes from normal expression and facial structure	Complete disappearance in every smile
Define the lip border more clearly	Anatomical limits, asymmetry, residual old filler and the risk of excessive volume	An exact copy of another person's lips or no swelling
Restore volume in one facial area	Whether that particular gel is suitable and whether the chosen anatomical area is appropriate for treatment	A genuine surgical lift of the tissues
Smooth a line that appears when frowning	Whether the crease is mainly caused by muscle activity	That filler can replace the action of botulinum toxin
Remove pigment changes, pores or a pronounced scar	Whether a skin-surface or medical cause calls for another treatment	That a volume-adding gel can cure skin colour or texture

Avoid selecting a filler because a social-media personality's lips look a certain way. Natural-looking results should be judged against your facial proportions at rest and in conversation, not a universal number of millilitres. A more modest change may feel easier psychologically, but it is still a medical procedure with real risks.

What evidence relates to Neuramis itself, rather than fillers in general?

A published randomised, multicentre phase III trial included 67 people: one nasolabial fold received Neuramis Deep and the other Restylane. In this specific comparison investigators found Neuramis Deep non-inferior for correcting the folds. This supports an effect of one particular formulation in one area. It does not demonstrate superiority everywhere on the face, or establish the effectiveness of all Neuramis versions.

Another randomised study in 58 participants compared Neuramis Deep Lidocaine with Perlane-L in moderate to severe nasolabial folds. Assessments took place at weeks 8, 16 and 24. Both products showed improvement; the difference in pain reduction between treated sides was not statistically significant. These findings do not guarantee how long volume will persist in an individual, particularly in a different treatment area.

“Non-inferior” within a trial is not the same as “best filler”. Such a statistical comparison addresses a prespecified endpoint, in a selected group followed for a limited time. Rare and serious blood-vessel complications may never occur in a study this small; their absence in a trial does not prove the risk is zero.

Descriptions of Neuramis often focus on elasticity, viscosity, cross-linking or added anaesthetic. These properties may help a clinician predict how the gel behaves, but are not substitutes for clinical studies of the exact version and indication. A technical label cannot ensure a natural result: gel placement and its appearance with movement depend on anatomy and practitioner experience.

What happens during the appointment, and what might you feel?

First the clinician assesses symmetry, proportions and movement, asks about earlier fillers and examines the skin in the proposed area. Mention cold sores, inflammation, allergies, illnesses, medicines and everything injected before, even if the brand escapes you. It may take additional documents or time to establish the nature of old filler. Unknown residual material should not simply be injected over without assessment.

You then discuss the goal, a patient-specific amount, possible asymmetry and alternatives. After preparing the skin, the clinician injects gel using a needle or, where appropriate, a blunt-tipped thin tube called a cannula. You might feel pressure, pinching or fullness. Lidocaine in certain versions may ease pain but cannot make the experience guaranteed painless. A cannula does not eliminate the risk of filler entering a blood vessel.

Immediately afterwards, swelling can make the area look larger than planned. Redness, tenderness, injection marks and bruising are possible. Avoid judging the final volume straight away, particularly under unfamiliar mirror lighting. Your clinician should explain when the shape can reasonably be assessed, what to do for expected swelling and which changes should be reported. Guidance about make-up, workouts, sun and massage varies with the area and injection technique.

How do you plan around work, meetings or travel?

You may feel physically well after treatment yet notice swelling or bruising for several days or longer; according to FDA guidance, ordinary local reactions often resolve over days to weeks. Nobody can promise “no marks tomorrow”. Side lighting can accentuate mild swelling in photographs more than ordinary conversation does. Make-up may conceal some bruise colour but not substantial swelling; use it only when your clinician says it is appropriate.

Before a wedding, public presentation or sunny holiday, allow for uncertainty rather than just pencilling in a single “recovery day”. Ask about a reasonable worst-case period of visible temporary changes, your follow-up appointment and how urgent complications would be handled. Postponing until after the event is often wiser than trying unverified home remedies to force swelling down.

The most serious complication: why should you recognise vascular warning signs?

With injectable fillers there is a risk of material entering a blood vessel unintentionally or compromising its blood supply through compression. Impaired circulation can damage skin or lead to tissue death; in certain vascular pathways visual impairment, including blindness, and stroke are possible. These outcomes are rare but may be irreversible. You cannot assess safety simply from the gel's softness or the absence of bruising.

Severe unusual pain, sudden blanching or grey-blue skin discolouration, a new change in vision or neurological symptoms (weakness of an arm or leg, facial drooping or changes in speech) need urgent medical assessment whether they begin during injection, soon afterwards or after you have gone home. If they develop during the procedure, tell the clinician immediately and stop the injection. For any vision change or stroke signs, call emergency services at once rather than waiting for the clinic to reply; suspected loss of blood supply to the skin also needs assessment without delay. Ask beforehand how rapid referral is arranged.

Hyaluronidase is an enzyme that can break down hyaluronic acid and may be considered by a qualified clinician in certain circumstances. However, a vial in the room does not mean that every complication can immediately be “dissolved” without harm, and it cannot guarantee restored vision. Appropriate management involves recognising signs, clinical decisions and sometimes urgent involvement of other specialists. Never try to massage an area that becomes unusually painful or discoloured.

Later problems can include infections, inflammation, lumps, migration and altered contours. Worsening redness, heat, fever, pus or increasing pain require urgent medical assessment. Not every lump is an infection and not every asymmetry should be dissolved immediately; the examination determines the next step.

When is it wiser not to have Neuramis now?

Postpone filler if there is an active infection or inflammation at the planned injection site until it is resolved. Tell the clinician about severe allergies, bleeding disorders, medicines increasing bleeding, immune conditions and previous filler reactions. If the formulation contains lidocaine, disclose any known allergy to local anaesthetics. Never stop prescribed medicines on your own for an aesthetic appointment.

Safety during pregnancy and breastfeeding has not been established adequately for elective cosmetic filler use; postponement is the cautious option. A skin disease, unusual growth, unexplained swelling or pain should be diagnosed before aesthetic treatment. Certain areas have particularly challenging vascular anatomy: promises that the nose, glabella or under-eye area can be filled “without risk” are inappropriate. The FDA specifically cautions against certain unapproved filler sites, but that is a US regulatory position, not Armenian approval guidance.

If you fear an irreversible change, discuss it before consenting. A small volume is not zero risk, and a resorbable hyaluronic acid gel does not mean the face instantly returns to its original state. You can consider skin care, another technique that better addresses the underlying issue, or a pause without injections. You do not need to alter your face to “keep up with ageing”.

Neuramis versus other fillers: what should you really compare?

Comparisons with Restylane are clinically grounded for Neuramis Deep in nasolabial folds, but not automatically in lips or chin. Comparing it with Juvederm or Stylage requires specifying each manufacturer's exact formulation; those brands also include different variants. Profhilo is discussed for a different goal and should not be treated as a direct replacement for every volumising filler. “Cheaper” and “thicker” alone tell you little about safety.

Before consenting, ask five questions: Which exact Neuramis formulation, and why is it appropriate for this area? What will change and what will stay the same? Which risks are especially relevant to your anatomy and history? What happens if a vascular problem is suspected? How will the result and later lumps or asymmetry be assessed? Ask for a complete quote covering product, consultation, review and any possible extra interventions, without relying on invented local averages.

Examine before-and-after photos critically: do lighting, expression, head angle, scale and elapsed time match? Immediately after injection, swelling can distort the apparent result. Reviews may describe communication and punctuality, but are not verified statistics on rare complications. A practitioner promising to duplicate someone else's face or eliminate all risk gives you good reason to seek a second opinion.

Neuramis has published studies, but a meaningful “yes” must be about the exact gel version, the particular area of your face and the actual healthcare team. Sometimes the gentlest answer is less treatment or none at all. Both deserve respect.

Additional questions

Can I buy Neuramis myself and bring it to my doctor?

That is not advisable. An unverified supplier cannot establish authenticity, correct temperature-controlled handling or lawful distribution; the device should pass through an appropriate medical supply chain.

What if an old filler was injected years ago and I cannot remember its name?

Share the approximate date, site and clinic, plus any remaining records or package photographs. State plainly that the material is unknown so the clinician can allow for that uncertainty in the examination and plan.

Does “Lidocaine” in the name mean an allergy test is always required?

Not automatically. The history of reactions, exact product instructions and clinical evaluation determine the approach. Do not try your own skin tests or ignore a known allergy.